{"gene":"POU5F1","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2005,"finding":"Oct3/4 and Cdx2 form a protein complex in ES cells that mediates reciprocal repression of their respective target genes; Cdx2 overexpression is sufficient to generate trophoblast stem cells and can mimic Oct3/4 repression-induced TE differentiation, while Cdx2 is dispensable for TE differentiation induced by Oct3/4 repression but essential for TS cell self-renewal.","method":"Forced expression/repression experiments in ES cells, co-immunoprecipitation to detect Oct3/4-Cdx2 complex, target gene analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, multiple orthogonal functional experiments, replicated across conditions in a rigorous single study","pmids":["16325584"],"is_preprint":false},{"year":2007,"finding":"Sox2's essential function in ES cells is to maintain the requisite level of Oct3/4 expression by regulating multiple transcription factors that affect Oct3/4 transcription; forced expression of Oct3/4 rescues pluripotency of Sox2-null ES cells, demonstrating that Oct3/4 is the key downstream effector of Sox2.","method":"Inducible Sox2-null ES cells, rescue experiments with forced Oct3/4 expression, gene expression analysis","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined rescue, multiple orthogonal methods in a single rigorous study","pmids":["17515932"],"is_preprint":false},{"year":2005,"finding":"Oct4 and Sox2 bind cooperatively to a composite sox-oct element in the distal enhancer of Pou5f1 (Oct4 gene itself) and the Sox2 enhancer in living ES cells, forming a positive autoregulatory loop; knockdown of either factor reduces both genes' enhancer activities and causes ES cell differentiation.","method":"Chromatin immunoprecipitation (ChIP) in mouse and human ES cells, in vitro binding with ESC nuclear extracts, RNAi knockdown","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal ChIP, in vitro binding, RNAi functional validation, replicated in two species","pmids":["15988017"],"is_preprint":false},{"year":2020,"finding":"OCT4 and SOX2 bind nucleosome-occupied motifs in a position-dependent manner: at one motif position the OCT4-SOX2 complex removes DNA from histones H2A and H3, while at an inverted motif only local DNA distortions are induced; OCT4 uses only one of its two DNA-binding domains (POUHD) at both positions.","method":"Cryo-electron microscopy structure determination, in vitro nucleosome binding assays at base-pair resolution, mutagenesis","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structures at two positions combined with in vitro biochemical assays and mutagenesis in a single rigorous study","pmids":["32327602"],"is_preprint":false},{"year":2013,"finding":"Zebrafish Pou5f1 (ortholog of mammalian Oct4) occupies SOX-POU binding sites at promoters of early zygotic genes before the onset of zygotic transcription and activates the earliest zygotic genes, positioning Pou5f1 and SOX-POU sites at the center of the zygotic gene activation network in vertebrates.","method":"ChIP-seq, transcriptome analysis of MZspg mutants, transgenic rescue experiments in zebrafish","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq plus loss-of-function genetics with transcriptome readout, multiple orthogonal methods","pmids":["23950494"],"is_preprint":false},{"year":2006,"finding":"Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in ES cells; Klf4 acts as a mediating factor that binds specifically to the proximal element of the Lefty1 promoter and is required because the Oct3/4-Sox2-dependent Lefty1 enhancer alone cannot be activated in differentiated cells.","method":"ES cell-specific enhancer identification, functional screening of ES-specific transcription factors, reporter assays, DNA microarray analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assays with multiple factors, single lab, supported by microarray data","pmids":["16954384"],"is_preprint":false},{"year":1991,"finding":"Oct-4 and adenovirus E1A are sufficient for distance-independent activation of the basal transcription machinery; E1A binds to the C-terminal POU domain of Oct-4 and can serve as a bridging factor between Oct-4 and the basal initiation complex; transcriptional activation depends on the transactivation domain linked to the POU domain and conserved domain 3 of E1A.","method":"Transient transfection reporter assays, deletion analysis of Oct-4 functional domains, protein interaction studies","journal":"Cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional domain deletion analysis with reporter assays, protein interaction mapping, single lab","pmids":["1830243"],"is_preprint":false},{"year":2009,"finding":"Dax1 (an orphan nuclear hormone receptor) directly interacts with Oct3/4 via the POU-specific domain of Oct3/4 in ES cells; this interaction abolishes DNA binding activity of Oct3/4 as shown by pulldown and gel shift assays; Dax1 inhibits Oct3/4 binding to Nanog and Oct3/4 promoter regions and its overexpression causes ES cell differentiation.","method":"Co-immunoprecipitation, GST pulldown, gel shift assays, ChIP, reporter assays, overexpression/knockdown in ES cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal biochemical methods (Co-IP, pulldown, gel shift, ChIP) converging on same mechanism in single study","pmids":["19528230"],"is_preprint":false},{"year":2005,"finding":"Ewing's sarcoma protein (EWS) interacts with Oct-4 via the POU domain of Oct-4 (with three independent binding sites on EWS), co-localizes with Oct-4 in pluripotent ES cells, and enhances Oct-4 transactivation activity; the EWS activation domain is sufficient to boost Oct-4-driven promoter activity.","method":"Bacterial two-hybrid screening, GST pulldown, co-immunoprecipitation, colocalization, reporter transactivation assays","journal":"Stem cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal pulldown and Co-IP plus functional reporter assays, single lab","pmids":["15917470"],"is_preprint":false},{"year":2012,"finding":"OCT4 is phosphorylated at 14 sites including T234 and S235 within the homeobox region; phosphorylation at T234/S235 negatively regulates OCT4 by interrupting sequence-specific DNA binding, reducing transcriptional activation from an OCT4-responsive reporter and decreasing reprogramming efficiency; ERK2 directly phosphorylates OCT4 at these sites in vitro.","method":"LC-MS/MS phosphoproteomics, mutagenesis of phosphorylation sites, reporter assays, reprogramming efficiency assays, in vitro kinase assays with ERK2","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus functional reporter and reprogramming readouts, multiple orthogonal methods in single study","pmids":["22474382"],"is_preprint":false},{"year":2010,"finding":"Oct-4 controls cell-cycle progression of ES cells: Oct-4 down-regulation inhibits proliferation by blocking G0/G1 progression; the p21 gene is a direct transcriptional target of Oct-4 repression, and p21 protein levels are inversely regulated by Oct-4 in ES cells.","method":"ZHBTc4 ES cells (inducible Oct-4 repression), flow cytometry cell cycle analysis, domain deletion analysis, reporter assays for p21","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible KO system with defined cell-cycle phenotype and target gene identification, single lab","pmids":["19968627"],"is_preprint":false},{"year":2008,"finding":"Oct3/4 is required for primordial germ cell (PGC) specification: ES-derived cells lacking Oct3/4 contribute to PGC precursor-like cells but fail to form PGCs in chimeric embryos; restoration of Oct3/4 expression rescues PGC specification.","method":"Chimeric embryo analysis with ZHBTc4 Oct3/4-null ES cells, doxycycline-controlled transgene system, dexamethasone-inducible rescue","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic loss-of-function with rescue experiment, two independent inducible systems confirming the same result","pmids":["18395706"],"is_preprint":false},{"year":2017,"finding":"CRISPR-Cas9 knockout of POU5F1 in human zygotes compromises blastocyst development; in POU5F1-null human cells, CDX2 (trophectoderm marker) and NANOG (epiblast marker) are both downregulated—contrasting with mouse where Pou5f1-null blastocysts maintain NANOG and only fail to maintain the blastocyst.","method":"CRISPR-Cas9 genome editing of human zygotes, single-cell transcriptomics, immunofluorescence","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct genetic loss-of-function in human embryos with transcriptomic readout, validated against mouse comparison","pmids":["28953884"],"is_preprint":false},{"year":2018,"finding":"OCT4 knockout in bovine embryos (via CRISPR/SCNT) results in absence of NANOG expression in the ICM of blastocysts while CDX2 remains restricted to TE cells; OCT4 is thus required for NANOG expression but not to suppress CDX2 in bovine ICM, mirroring human but not mouse embryology.","method":"CRISPR-Cas9 OCT4 knockout, somatic cell nuclear transfer, immunofluorescence in bovine blastocysts","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct genetic KO in a non-mouse mammalian model, multiple lineage markers assessed, convergent with human data","pmids":["29483258"],"is_preprint":false},{"year":2021,"finding":"Rapid auxin-degron-mediated OCT4 depletion shows that immediate downstream effects of OCT4 loss are reduced expression of key pluripotency factors and global depletion of H3K27ac at active enhancers; trophectoderm marker upregulation is a subsequent rather than immediate event; NANOG binding to the genome is enhanced (not reduced) upon OCT4 loss.","method":"Auxin-inducible degron system for rapid protein depletion, ChIP-seq for H3K27ac, NANOG ChIP-seq, transcriptomics","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — acute protein depletion system with ChIP-seq and transcriptomic readouts, multiple orthogonal methods, single lab","pmids":["34143975"],"is_preprint":false},{"year":2021,"finding":"OCT4 is required for activation of the JAK/STAT signaling machinery (but not most other pluripotency-associated transcription factors) in the early mouse embryo ICM; OCT4 null ICMs ectopically activate trophectoderm genes and show upregulation of the lysosomal pathway and dysregulation of glycolytic enzymes, implicating OCT4 in metabolic regulation.","method":"Single-cell transcriptomics and quantitative immunofluorescence of OCT4-null blastocysts","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single-cell transcriptomics of genetic KO embryos, single lab, mechanistic inference from pathway analysis","pmids":["33452132"],"is_preprint":false},{"year":2016,"finding":"OCT4 binds low-accessible genomic regions and is required for proper enhancer and gene activation in response to external differentiation signals (RA/RAR:RXR or Wnt/β-catenin); OCT4 recruits co-regulators and signal-dependent transcription factors to these sites, acting as an integral component of signal-regulated transcriptional processes.","method":"Genomic approaches (ChIP-seq), loss- and gain-of-function genetic models, overexpression in kidney cell line","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq with genetic loss/gain-of-function, multiple genomic datasets, single lab","pmids":["27499297"],"is_preprint":false},{"year":2021,"finding":"Nucleosome binding by OCT4 is encoded within its DNA-binding domain but can be uncoupled from free-DNA binding; stable OCT4-nucleosome interactions are continuously required for maintaining accessibility of pluripotency enhancers in stem cells; both uncoupling and enhancing nucleosome binding are detrimental to reprogramming efficiency.","method":"Systematic domain dissection/mutagenesis, ATAC-seq, ChIP-seq, reprogramming efficiency assays","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — systematic mutagenesis with multiple orthogonal genomic and functional readouts in a single comprehensive study","pmids":["34354236"],"is_preprint":false},{"year":2020,"finding":"OCT4 binds the LIN28B distal enhancer nucleosome preferentially at sequences near the entry/exit site; OCT4 contacts the histone H3 N-terminal region (near entry/exit site) as shown by crosslinking mass spectrometry; linker histone H1 competes with OCT4 for nucleosome binding.","method":"Cryo-EM single-particle analysis, chemical mapping, crosslinking mass spectrometry, mutational analysis, in vitro nucleosome binding assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure combined with chemical mapping and crosslinking MS, multiple orthogonal structural methods, single lab","pmids":["32678275"],"is_preprint":false},{"year":2023,"finding":"High-resolution cryo-EM structures of OCT4 bound to LIN28B nucleosome reveal three OCT4s binding pre-positioned nucleosomal DNA: two use POUS domains, one uses POUS-loop-POUHD; the POUHD domain acts as a wedge to unwrap ~25 bp of DNA; multiple OCT4s cooperatively open H1-condensed nucleosome arrays.","method":"Cryo-EM structure determination, biochemical nucleosome binding and opening assays, analysis of genomic data","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution cryo-EM structures with biochemical functional validation and genomic data analysis","pmids":["37327775"],"is_preprint":false},{"year":2018,"finding":"WWP2 catalyzes ubiquitination of OCT4; disruption of WWP2-mediated ubiquitination or Wwp2 ablation increases OCT4 protein stability and promotes reprogramming efficiency; elevated H3K4 methylation accompanies increased OCT4 stability; OCT4 directly activates expression of Ash2l-b, a H3K4 methyltransferase complex subunit required for reprogramming.","method":"Identification of ubiquitin conjugation sites, in vitro ubiquitination assays, Wwp2 knockout mouse embryonic fibroblasts, reprogramming efficiency assays, ChIP","journal":"Stem cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro ubiquitination assay plus genetic KO plus reprogramming functional readout, multiple orthogonal methods","pmids":["30269953"],"is_preprint":false},{"year":2015,"finding":"DPF2 (a PHD finger protein) physically interacts with OCT4 in ES cells and acts as an E3 ubiquitin ligase that assembles K48-linked polyubiquitin chains on OCT4, targeting it for proteasomal degradation; DPF2 also redistributes nuclear OCT4 independently of ubiquitination.","method":"Co-immunoprecipitation, GST pulldown, in vitro ubiquitination assay, siRNA knockdown, overexpression in 293 cells","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro ubiquitination assay and Co-IP/pulldown, single lab, multiple methods","pmids":["26417682"],"is_preprint":false},{"year":2008,"finding":"Oct3/4 expression in ES cells is regulated by STAT3 and Oct3/4 itself; both STAT3 and Oct3/4 directly bind putative sites in the Dax1 promoter/enhancer region; suppression of STAT3 or Oct3/4 reduces Dax1 expression, establishing that Oct3/4 activates Dax1 transcription to maintain ES cell self-renewal.","method":"Reporter assay, ChIP, gel shift assay, siRNA knockdown","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus gel shift plus reporter assays, single lab","pmids":["18471437"],"is_preprint":false},{"year":2004,"finding":"Zebrafish pou5f1/pou2 (maternal and zygotic) is required for endoderm specification: maternal-zygotic spg mutants fail to maintain sox32 expression and do not express sox17, resulting in loss of endodermal tissue; Pou5f1 acts upstream of sox32 to induce sox17 in endodermal precursors; a Pou5f1-VP16 activator fusion rescues gastrulation and endoderm.","method":"Maternal-zygotic mutant (MZspg) analysis, mRNA rescue injection, Pou5f1-VP16 overexpression, gene expression analysis in zebrafish","journal":"Current biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis via maternal-zygotic mutant plus activator fusion rescue, clean pathway placement","pmids":["14711414"],"is_preprint":false},{"year":2011,"finding":"In zebrafish, Pou5f1 acts as a transcriptional activator for dorsoventral patterning; Pou5f1 directly binds phylogenetically conserved Oct/Pou5f1 sites in the vox promoter (confirmed by ChIP and in vitro binding); Pou5f1 indirectly controls fgf8a expression (Pou5f1-En repressor induces fgf8, suggesting repression), and coordinates BMP signaling network activity.","method":"Pou5f1-VP16 and Pou5f1-En fusion overexpression in zebrafish, ChIP, in vitro DNA binding, cycloheximide treatment to distinguish direct vs indirect targets","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus in vitro binding plus functional fusion protein experiments, single lab","pmids":["21621531"],"is_preprint":false},{"year":2006,"finding":"NOBOX binds directly to NOBOX binding elements (NBEs: TAATTG, TAGTTG, TAATTA) in the Pou5f1 promoter (-426 site) and augments Pou5f1 transcriptional activity; NOBOX occupies the Pou5f1 promoter in vivo as shown by ChIP.","method":"SELEX (cyclic amplification of sequence target), mutation analysis, luciferase reporter assay, ChIP","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — SELEX binding characterization plus ChIP plus reporter assay, single lab","pmids":["16997917"],"is_preprint":false},{"year":1994,"finding":"The proximal Oct-4 promoter contains binding sites for Sp1 and three direct repeats of an AGGTCA-like sequence; nuclear receptors ARP-1 and RAR negatively regulate Oct-4 expression by binding these elements as shown by binding and transient transfection assays.","method":"Binding assays, transient transfection reporter assays, promoter deletion analysis","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — binding assays plus functional reporter assays, single lab","pmids":["8152920"],"is_preprint":false},{"year":2013,"finding":"Oct4 transiently activates Meis1a expression via direct binding to the Meis1 promoter (accompanied by histone H3 acetylation and 5-hmC), while Meis1a in turn suppresses Oct4 expression by direct association with the Oct4 promoter together with HDAC1; this crosstalk is required for neural differentiation.","method":"ChIP, luciferase reporter analysis, ectopic expression, siRNA knockdown in P19 EC cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assays plus reciprocal loss/gain of function, single lab","pmids":["23451132"],"is_preprint":false},{"year":2017,"finding":"OCT4 and SOX2 function as transcriptional activators during reprogramming; substituting SOX2-VP16 for wild-type SOX2 increases reprogramming efficiency and enhancer strength, while SOX2-HP1 (repressor) eliminates reprogramming; at early reprogramming stages, DNA-bound OCT4 is embedded in putative enhancers, about half of which are created de novo.","method":"Reprogramming efficiency assays with activation/repression domain fusions, ChIP-seq at early reprogramming stages","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional domain swap with ChIP-seq, single lab, clean epistatic readout","pmids":["28813671"],"is_preprint":false},{"year":2005,"finding":"The EWSR1-POU5F1 fusion protein (from t(6;22) bone tumor) binds DNA with the same sequence specificity as Oct-4, has higher transactivation activity than parental Oct-4, induces expression of fgf-4 and nanog, and causes tumorigenic growth in nude mice when expressed in Oct-4-null ES cells, establishing the fusion as an oncogenic transcription factor.","method":"DNA binding assays, reporter assays, target gene expression analysis (fgf-4, nanog), nude mouse tumorigenicity assay with Oct-4-null ZHBTc4 ES cells","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional biochemical assays plus in vivo tumorigenic assay, single lab","pmids":["17564582"],"is_preprint":false},{"year":2022,"finding":"In endothelial cells, OCT4 directly targets the ABC transporter ABCG2; the OCT4/ABCG2 axis maintains endothelial metabolic homeostasis by regulating intracellular heme accumulation and related ROS production; EC-specific Oct4 knockout increases endothelial-to-mesenchymal transitions, plaque neovascularization, and mitochondrial dysfunction.","method":"EC-specific Oct4 conditional KO mice, single-cell RNA-seq, EC-lineage tracing, ChIP to confirm ABCG2 as direct OCT4 target","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined phenotype and direct target identification by ChIP, single lab","pmids":["35325071"],"is_preprint":false}],"current_model":"POU5F1/OCT4 is a pioneer POU-family transcription factor that maintains pluripotency by forming cooperative complexes with SOX2, NANOG, and KLF4 to activate or repress target gene networks; it directly binds nucleosomal DNA using its POUS and POUHD domains to open chromatin at pluripotency enhancers, is negatively regulated by phosphorylation (ERK2 at T234/S235) and ubiquitination (WWP2-mediated K48-linked polyubiquitin/proteasomal degradation), is inhibited by DAX1 binding to its POU-specific domain which blocks DNA binding, represses p21 to promote cell-cycle S-phase entry in ES cells, and is required cell-autonomously for NANOG expression and inner cell mass lineage maintenance in mammalian blastocysts while also directing primordial germ cell specification and, in zebrafish, zygotic genome activation."},"narrative":{"mechanistic_narrative":"POU5F1/OCT4 is a POU-family transcription factor that establishes and maintains the pluripotent state by acting as a pioneer factor capable of engaging nucleosomal DNA at otherwise inaccessible regulatory elements [PMID:32327602, PMID:34354236]. OCT4 operates within a self-reinforcing core network: it binds cooperatively with SOX2 at a composite sox-oct element in its own distal enhancer and in the Sox2 enhancer, forming a positive autoregulatory loop whose disruption triggers differentiation [PMID:15988017], and SOX2's essential contribution is to sustain OCT4 levels, with forced OCT4 expression rescuing Sox2-null cells [PMID:17515932]. At target loci OCT4 recruits additional factors—KLF4 at the Lefty1 promoter [PMID:16954384]—and integrates signal-dependent transcription factors at low-accessibility enhancers during RA and Wnt responses [PMID:27499297], while its reciprocal repressive complex with CDX2 enforces the boundary between pluripotency and trophectoderm fate [PMID:16325584]. Structurally, OCT4 binds nucleosome-occluded motifs in a position-dependent manner, using its POUHD domain as a wedge to unwrap DNA from histones, contacting the histone H3 N-terminal region near the entry/exit site, and acting in multiples to cooperatively open H1-condensed nucleosome arrays—an activity continuously required to maintain enhancer accessibility [PMID:32327602, PMID:32678275, PMID:37327775, PMID:34354236]. OCT4 activity is tuned by post-translational control: ERK2 phosphorylates it at T234/S235 within the homeobox to block DNA binding [PMID:22474382], WWP2 ubiquitinates it to limit protein stability [PMID:30269953], and DAX1 binds the POU-specific domain to abolish DNA binding [PMID:19528230]; reciprocally, OCT4 directly activates Dax1 transcription, creating a feedback circuit [PMID:18471437]. Functionally, OCT4 represses p21 to promote cell-cycle progression in ES cells [PMID:19968627], is required for primordial germ cell specification [PMID:18395706], and is essential for maintaining the inner cell mass and NANOG expression in human and bovine blastocysts [PMID:28953884, PMID:29483258]. In zebrafish the ortholog drives zygotic genome activation and germ-layer patterning [PMID:23950494, PMID:14711414]. The EWSR1-POU5F1 fusion behaves as an oncogenic transcription factor with OCT4 DNA-binding specificity and elevated transactivation [PMID:17564582].","teleology":[{"year":1991,"claim":"Established that OCT4 functions as a transcriptional activator able to engage the basal machinery through its POU and transactivation domains, defining its activity as a sequence-specific activator.","evidence":"Transient transfection reporter assays with domain deletion and E1A bridging in cultured cells","pmids":["1830243"],"confidence":"Medium","gaps":["Used a viral bridging factor rather than endogenous coactivators","Did not address chromatin or nucleosomal targets"]},{"year":1994,"claim":"Defined how OCT4 expression itself is set, showing nuclear receptors ARP-1 and RAR negatively regulate the proximal Oct-4 promoter, placing OCT4 under upstream signal control.","evidence":"Binding and transient transfection reporter assays with promoter deletions","pmids":["8152920"],"confidence":"Medium","gaps":["Promoter-reporter context only","In vivo relevance to embryonic regulation not tested"]},{"year":2004,"claim":"Placed the OCT4 ortholog in a developmental hierarchy, showing zebrafish Pou5f1 acts upstream of sox32 to specify endoderm, demonstrating an instructive role in germ-layer fate beyond stem cell maintenance.","evidence":"Maternal-zygotic spg mutant analysis with mRNA and Pou5f1-VP16 rescue in zebrafish","pmids":["14711414"],"confidence":"High","gaps":["Direct vs indirect targets of sox32 induction not fully resolved","Mammalian endoderm relevance not addressed"]},{"year":2005,"claim":"Resolved the core pluripotency wiring, showing OCT4 and SOX2 bind cooperatively to a composite element to form a positive autoregulatory loop sustaining both genes.","evidence":"ChIP in mouse and human ES cells, in vitro binding, and RNAi knockdown","pmids":["15988017"],"confidence":"High","gaps":["Did not establish nucleosomal binding mode","Full enhancer co-factor composition not defined"]},{"year":2005,"claim":"Demonstrated reciprocal antagonism between OCT4 and CDX2 as the molecular switch governing the pluripotency-versus-trophectoderm decision.","evidence":"Forced expression/repression in ES cells with Co-IP and target gene analysis","pmids":["16325584"],"confidence":"High","gaps":["Stoichiometry and structural basis of the OCT4-CDX2 complex unknown","Generality across species not tested"]},{"year":2005,"claim":"Identified EWS as an OCT4 coactivator binding the POU domain, beginning to define the partner proteins that potentiate OCT4 transactivation.","evidence":"Bacterial two-hybrid, GST pulldown, Co-IP, colocalization, and reporter assays","pmids":["15917470"],"confidence":"Medium","gaps":["Endogenous requirement in ES cells not shown by loss-of-function","Single-lab interaction mapping"]},{"year":2006,"claim":"Showed OCT4 acts combinatorially with KLF4 to activate target promoters, explaining why OCT4-SOX2 enhancers require additional context-specific mediators.","evidence":"Reporter assays, factor screening, and microarray analysis in ES cells","pmids":["16954384"],"confidence":"Medium","gaps":["Single target locus (Lefty1) examined","Direct OCT4-KLF4 physical interaction not established"]},{"year":2007,"claim":"Established that SOX2's essential role in ES cells is to maintain OCT4 levels, ordering the network with OCT4 as the key downstream effector.","evidence":"Inducible Sox2-null ES cells rescued by forced Oct3/4 expression","pmids":["17515932"],"confidence":"High","gaps":["Did not exclude SOX2-independent OCT4 functions","Mechanism of indirect OCT4 regulation by SOX2 only partly defined"]},{"year":2008,"claim":"Connected OCT4 to germ-cell fate and to a feedback circuit, showing OCT4 is required cell-autonomously for primordial germ cell specification and directly activates Dax1 transcription.","evidence":"Chimeric embryo analysis with inducible Oct3/4-null ES cells; ChIP, gel shift, and reporter assays for Dax1","pmids":["18395706","18471437"],"confidence":"High","gaps":["Direct OCT4 PGC target genes not enumerated","Functional consequence of the OCT4-Dax1 loop on threshold control not quantified"]},{"year":2009,"claim":"Identified DAX1 as a direct inhibitor that binds the OCT4 POU-specific domain and abolishes DNA binding, defining a protein-level off-switch.","evidence":"Co-IP, GST pulldown, gel shift, ChIP, and reporter assays in ES cells","pmids":["19528230"],"confidence":"High","gaps":["Physiological trigger for DAX1-mediated inhibition unclear","Stoichiometric regulation of the OCT4/DAX1 feedback not defined"]},{"year":2010,"claim":"Linked OCT4 to cell-cycle control, showing it directly represses p21 to promote G0/G1 progression in ES cells.","evidence":"Inducible Oct-4 repression, flow cytometry, domain deletion, and p21 reporter assays","pmids":["19968627"],"confidence":"Medium","gaps":["Direct binding at the endogenous p21 locus only inferred from reporter","Single-lab study"]},{"year":2012,"claim":"Defined a kinase-driven brake on OCT4, showing ERK2 phosphorylates T234/S235 in the homeobox to interrupt DNA binding and lower reprogramming efficiency.","evidence":"Phosphoproteomics, site mutagenesis, in vitro ERK2 kinase assay, and reporter/reprogramming readouts","pmids":["22474382"],"confidence":"High","gaps":["Upstream signals controlling ERK2-OCT4 phosphorylation in vivo not mapped","Other phosphosites' functions unresolved"]},{"year":2013,"claim":"Generalized OCT4 to vertebrate zygotic genome activation, showing zebrafish Pou5f1 occupies SOX-POU sites and activates the earliest zygotic genes before transcription onset.","evidence":"ChIP-seq and transcriptome analysis of MZspg mutants with transgenic rescue","pmids":["23950494"],"confidence":"High","gaps":["Pioneer mechanism at ZGA loci not structurally resolved here","Mammalian ZGA role not directly tested"]},{"year":2016,"claim":"Showed OCT4 binds low-accessibility regions and recruits signal-dependent factors, casting it as an integrator of external differentiation signals rather than a pluripotency-only factor.","evidence":"ChIP-seq with loss/gain-of-function in genetic models and a kidney cell line","pmids":["27499297"],"confidence":"Medium","gaps":["Co-regulator identity at signal-responsive sites only partly defined","Performed in part in a non-pluripotent cell line"]},{"year":2020,"claim":"Provided the structural mechanism of OCT4 as a pioneer factor, showing position-dependent nucleosome engagement that removes DNA from histones using a single DNA-binding domain.","evidence":"Cryo-EM at base-pair resolution with in vitro nucleosome binding and mutagenesis; complementary cryo-EM/crosslinking MS at the LIN28B enhancer","pmids":["32327602","32678275"],"confidence":"High","gaps":["In vitro reconstitution may not capture full cellular cofactor context","How motif orientation maps to genome-wide outcomes unresolved"]},{"year":2021,"claim":"Dissected the temporal and structural requirements of OCT4 in stem cells, showing nucleosome binding is encoded in the DBD, must be balanced for reprogramming, and that acute OCT4 loss first collapses enhancer H3K27ac and pluripotency factor expression.","evidence":"Systematic mutagenesis with ATAC/ChIP-seq; auxin-degron rapid depletion with H3K27ac and NANOG ChIP-seq","pmids":["34354236","34143975"],"confidence":"High","gaps":["Mechanism by which NANOG binding increases upon OCT4 loss not explained","Direct vs indirect enhancer effects not fully separated"]},{"year":2021,"claim":"Extended OCT4's embryonic role to signaling and metabolism, showing it is required for JAK/STAT activation and metabolic gene regulation in the ICM.","evidence":"Single-cell transcriptomics and quantitative immunofluorescence of OCT4-null mouse blastocysts","pmids":["33452132"],"confidence":"Medium","gaps":["Direct OCT4 targets in the JAK/STAT and metabolic pathways not defined","Mechanistic inference from pathway-level transcriptomics"]},{"year":2017,"claim":"Revealed species-specific lineage requirements, showing human POU5F1 loss downregulates both NANOG and CDX2, contrasting with the mouse trophectoderm-restriction model.","evidence":"CRISPR-Cas9 editing of human zygotes with single-cell transcriptomics and immunofluorescence","pmids":["28953884"],"confidence":"High","gaps":["Molecular basis of human-mouse divergence not resolved","Direct human OCT4 target genes not mapped"]},{"year":2018,"claim":"Confirmed the human-like requirement in a second mammal and defined OCT4 protein turnover, showing OCT4 is needed for NANOG in bovine ICM and that WWP2 ubiquitination limits OCT4 stability and reprogramming.","evidence":"CRISPR/SCNT knockout in bovine embryos; ubiquitination site mapping, in vitro ubiquitination, Wwp2-null MEFs, and reprogramming assays","pmids":["29483258","30269953"],"confidence":"High","gaps":["Signals controlling WWP2-OCT4 turnover in vivo not defined","Link between OCT4 stability and H3K4 methylation only correlative in part"]},{"year":2023,"claim":"Achieved high-resolution mechanism of cooperative chromatin opening, showing three OCT4 molecules engage a pre-positioned nucleosome and use POUHD as a wedge to unwrap DNA and open H1-condensed arrays.","evidence":"High-resolution cryo-EM with biochemical nucleosome opening assays and genomic analysis","pmids":["37327775"],"confidence":"High","gaps":["In vivo stoichiometry of multi-OCT4 binding not established","How cooperativity is regulated by partner factors unknown"]},{"year":2022,"claim":"Documented a somatic, non-pluripotency role, showing OCT4 directly regulates ABCG2 to maintain endothelial metabolic homeostasis and protect against vascular dysfunction.","evidence":"EC-specific Oct4 conditional KO mice, scRNA-seq, lineage tracing, and ChIP for ABCG2","pmids":["35325071"],"confidence":"Medium","gaps":["Mechanism of OCT4 reactivation in adult endothelium unclear","Single-lab, single tissue context"]},{"year":null,"claim":"How OCT4 selects between activation and repression at a given locus, and how its pioneer nucleosome-opening activity is integrated with partner availability, post-translational state, and species-specific lineage outcomes, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking phosphorylation/ubiquitination state to genome-wide binding outcomes","Determinants of activator vs repressor behavior at individual enhancers undefined","Molecular basis of human/bovine vs mouse lineage divergence unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,6,23,28,29]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,7,9,17,19]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[18,19]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,21]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[3,17,18,19]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,4,16,28]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[11,12,13,23]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[3,17,19]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[10]}],"complexes":[],"partners":["SOX2","CDX2","DAX1","KLF4","EWS","WWP2","DPF2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q01860","full_name":"POU domain, class 5, transcription factor 1","aliases":["Octamer-binding protein 3","Oct-3","Octamer-binding protein 4","Oct-4","Octamer-binding transcription factor 3","OTF-3"],"length_aa":360,"mass_kda":38.6,"function":"Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3'). Forms a trimeric complex with SOX2 or SOX15 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206. Critical for early embryogenesis and for embryonic stem cell pluripotency","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q01860/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POU5F1","classification":"Not Classified","n_dependent_lines":19,"n_total_lines":1208,"dependency_fraction":0.015728476821192054},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/POU5F1","total_profiled":1310},"omim":[{"mim_id":"621222","title":"LINE1-TYPE TRANSPOSASE DOMAIN-CONTAINING PROTEIN 1; L1TD1","url":"https://www.omim.org/entry/621222"},{"mim_id":"619623","title":"LEUCINE-RICH REPEAT NEURONAL PROTEIN 1; LRRN1","url":"https://www.omim.org/entry/619623"},{"mim_id":"619458","title":"METHYL-CpG-BINDING DOMAIN PROTEIN 6; MBD6","url":"https://www.omim.org/entry/619458"},{"mim_id":"619037","title":"LEUCINE-RICH REPEAT-CONTAINING PROTEIN 34; LRRC34","url":"https://www.omim.org/entry/619037"},{"mim_id":"618690","title":"PSORIASIS SUSCEPTIBILITY 1 CANDIDATE GENE 3, NONCODING; PSORS1C3","url":"https://www.omim.org/entry/618690"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Mitochondria","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"kidney","ntpm":16.8}],"url":"https://www.proteinatlas.org/search/POU5F1"},"hgnc":{"alias_symbol":["OCT3","Oct4","MGC22487","OCT-4","Oct3/4"],"prev_symbol":["OTF3"]},"alphafold":{"accession":"Q01860","domains":[{"cath_id":"1.10.260.40","chopping":"135-228","consensus_level":"high","plddt":89.1229,"start":135,"end":228},{"cath_id":"1.10.10.60","chopping":"238-286","consensus_level":"high","plddt":94.888,"start":238,"end":286}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01860","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q01860-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q01860-F1-predicted_aligned_error_v6.png","plddt_mean":64.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POU5F1","jax_strain_url":"https://www.jax.org/strain/search?query=POU5F1"},"sequence":{"accession":"Q01860","fasta_url":"https://rest.uniprot.org/uniprotkb/Q01860.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q01860/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q01860"}},"corpus_meta":[{"pmid":"16325584","id":"PMC_16325584","title":"Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16325584","citation_count":932,"is_preprint":false},{"pmid":"17515932","id":"PMC_17515932","title":"Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.","date":"2007","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17515932","citation_count":905,"is_preprint":false},{"pmid":"15882627","id":"PMC_15882627","title":"Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15882627","citation_count":681,"is_preprint":false},{"pmid":"11463946","id":"PMC_11463946","title":"Oct-4: gatekeeper in the beginnings of mammalian development.","date":"2001","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/11463946","citation_count":619,"is_preprint":false},{"pmid":"15988017","id":"PMC_15988017","title":"Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15988017","citation_count":547,"is_preprint":false},{"pmid":"12727846","id":"PMC_12727846","title":"POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12727846","citation_count":516,"is_preprint":false},{"pmid":"18612434","id":"PMC_18612434","title":"Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18612434","citation_count":404,"is_preprint":false},{"pmid":"9507072","id":"PMC_9507072","title":"Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9507072","citation_count":388,"is_preprint":false},{"pmid":"11090438","id":"PMC_11090438","title":"Expression pattern of Oct-4 in preimplantation embryos of different species.","date":"2000","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11090438","citation_count":291,"is_preprint":false},{"pmid":"12528890","id":"PMC_12528890","title":"Stem cell pluripotency and transcription factor Oct4.","date":"2002","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/12528890","citation_count":270,"is_preprint":false},{"pmid":"28953884","id":"PMC_28953884","title":"Genome editing reveals a role for OCT4 in human embryogenesis.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28953884","citation_count":266,"is_preprint":false},{"pmid":"17205510","id":"PMC_17205510","title":"OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer.","date":"2007","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17205510","citation_count":223,"is_preprint":false},{"pmid":"21156086","id":"PMC_21156086","title":"Role of Oct4 in maintaining and regaining stem cell pluripotency.","date":"2010","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/21156086","citation_count":207,"is_preprint":false},{"pmid":"16954384","id":"PMC_16954384","title":"Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in embryonic stem cells.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16954384","citation_count":194,"is_preprint":false},{"pmid":"9819561","id":"PMC_9819561","title":"In line with our ancestors: Oct-4 and the mammalian germ.","date":"1998","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9819561","citation_count":191,"is_preprint":false},{"pmid":"10694754","id":"PMC_10694754","title":"Oct-4: control of totipotency and germline determination.","date":"2000","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/10694754","citation_count":190,"is_preprint":false},{"pmid":"23950494","id":"PMC_23950494","title":"Pou5f1 transcription factor controls zygotic gene activation in vertebrates.","date":"2013","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23950494","citation_count":190,"is_preprint":false},{"pmid":"32327602","id":"PMC_32327602","title":"Mechanisms of OCT4-SOX2 motif readout on nucleosomes.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32327602","citation_count":187,"is_preprint":false},{"pmid":"1830243","id":"PMC_1830243","title":"A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells.","date":"1991","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/1830243","citation_count":175,"is_preprint":false},{"pmid":"15105401","id":"PMC_15105401","title":"Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads.","date":"2004","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15105401","citation_count":168,"is_preprint":false},{"pmid":"16229821","id":"PMC_16229821","title":"Oct4 pseudogenes are transcribed in cancers.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16229821","citation_count":158,"is_preprint":false},{"pmid":"25232507","id":"PMC_25232507","title":"The Oct4 protein: more than a magic stemness marker.","date":"2014","source":"American journal of stem cells","url":"https://pubmed.ncbi.nlm.nih.gov/25232507","citation_count":155,"is_preprint":false},{"pmid":"25408886","id":"PMC_25408886","title":"Role of Oct4 in the early embryo development.","date":"2014","source":"Cell regeneration (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25408886","citation_count":155,"is_preprint":false},{"pmid":"9835353","id":"PMC_9835353","title":"The molecular biology of Oct-4 in the early mouse embryo.","date":"1998","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/9835353","citation_count":149,"is_preprint":false},{"pmid":"11309664","id":"PMC_11309664","title":"Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences.","date":"2001","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/11309664","citation_count":144,"is_preprint":false},{"pmid":"19584295","id":"PMC_19584295","title":"Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma.","date":"2009","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/19584295","citation_count":140,"is_preprint":false},{"pmid":"11044462","id":"PMC_11044462","title":"Oct-4 expression in inner cell mass and trophectoderm of human blastocysts.","date":"2000","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11044462","citation_count":139,"is_preprint":false},{"pmid":"24145198","id":"PMC_24145198","title":"OCT4: dynamic DNA binding pioneers stem cell pluripotency.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24145198","citation_count":126,"is_preprint":false},{"pmid":"14711414","id":"PMC_14711414","title":"Zebrafish pou5f1/pou2, homolog of mammalian Oct4, functions in the endoderm specification cascade.","date":"2004","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/14711414","citation_count":126,"is_preprint":false},{"pmid":"18032701","id":"PMC_18032701","title":"Absence of OCT4 expression in somatic tumor cell lines.","date":"2007","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/18032701","citation_count":108,"is_preprint":false},{"pmid":"29483258","id":"PMC_29483258","title":"OCT4/POU5F1 is required for NANOG expression in bovine blastocysts.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29483258","citation_count":95,"is_preprint":false},{"pmid":"19968627","id":"PMC_19968627","title":"Oct-4 controls cell-cycle progression of embryonic stem cells.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19968627","citation_count":93,"is_preprint":false},{"pmid":"17261754","id":"PMC_17261754","title":"From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion.","date":"2006","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17261754","citation_count":91,"is_preprint":false},{"pmid":"22474382","id":"PMC_22474382","title":"Phosphorylation regulates human OCT4.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22474382","citation_count":90,"is_preprint":false},{"pmid":"32428834","id":"PMC_32428834","title":"Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4+/Nanog+ NSCLC cells.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32428834","citation_count":84,"is_preprint":false},{"pmid":"22009686","id":"PMC_22009686","title":"Concise review: Oct4 and more: the reprogramming expressway.","date":"2012","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/22009686","citation_count":83,"is_preprint":false},{"pmid":"15729702","id":"PMC_15729702","title":"EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12).","date":"2005","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15729702","citation_count":81,"is_preprint":false},{"pmid":"16421218","id":"PMC_16421218","title":"Oct-4 expression in human endometrium.","date":"2006","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/16421218","citation_count":76,"is_preprint":false},{"pmid":"8152920","id":"PMC_8152920","title":"Regulation of the Oct-4 gene by nuclear receptors.","date":"1994","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8152920","citation_count":76,"is_preprint":false},{"pmid":"29773834","id":"PMC_29773834","title":"Embryonic POU5F1 is Required for Expanded Bovine Blastocyst Formation.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29773834","citation_count":75,"is_preprint":false},{"pmid":"16997917","id":"PMC_16997917","title":"Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16997917","citation_count":75,"is_preprint":false},{"pmid":"20212526","id":"PMC_20212526","title":"Zebrafish Pou5f1-dependent transcriptional networks in temporal control of early development.","date":"2010","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/20212526","citation_count":70,"is_preprint":false},{"pmid":"12890723","id":"PMC_12890723","title":"Oct-4 expression in pluripotent cells of the rhesus monkey.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12890723","citation_count":68,"is_preprint":false},{"pmid":"21394007","id":"PMC_21394007","title":"Clinical implications of stem cell gene Oct-4 expression in breast cancer.","date":"2011","source":"Annals of surgery","url":"https://pubmed.ncbi.nlm.nih.gov/21394007","citation_count":68,"is_preprint":false},{"pmid":"27499297","id":"PMC_27499297","title":"OCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27499297","citation_count":62,"is_preprint":false},{"pmid":"17122441","id":"PMC_17122441","title":"Bone marrow Oct3/4+ cells differentiate into cardiac myocytes via age-dependent paracrine mechanisms.","date":"2006","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/17122441","citation_count":56,"is_preprint":false},{"pmid":"19528230","id":"PMC_19528230","title":"Dax1 binds to Oct3/4 and inhibits its transcriptional activity in embryonic stem cells.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19528230","citation_count":54,"is_preprint":false},{"pmid":"11069619","id":"PMC_11069619","title":"The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602.","date":"2000","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/11069619","citation_count":52,"is_preprint":false},{"pmid":"18395706","id":"PMC_18395706","title":"Requirement of Oct3/4 function for germ cell specification.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18395706","citation_count":50,"is_preprint":false},{"pmid":"33452132","id":"PMC_33452132","title":"OCT4 induces embryonic pluripotency via STAT3 signaling and metabolic mechanisms.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33452132","citation_count":50,"is_preprint":false},{"pmid":"27065334","id":"PMC_27065334","title":"OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/27065334","citation_count":50,"is_preprint":false},{"pmid":"21419292","id":"PMC_21419292","title":"Expression pattern of Oct-4, Sox2, and c-Myc in the primary culture of human dental pulp derived cells.","date":"2011","source":"Journal of endodontics","url":"https://pubmed.ncbi.nlm.nih.gov/21419292","citation_count":50,"is_preprint":false},{"pmid":"34354236","id":"PMC_34354236","title":"Dissecting OCT4 defines the role of nucleosome binding in pluripotency.","date":"2021","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/34354236","citation_count":49,"is_preprint":false},{"pmid":"15917470","id":"PMC_15917470","title":"Stimulation of Oct-4 activity by Ewing's sarcoma protein.","date":"2005","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/15917470","citation_count":47,"is_preprint":false},{"pmid":"32678275","id":"PMC_32678275","title":"Nucleosome binding by the pioneer transcription factor OCT4.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32678275","citation_count":44,"is_preprint":false},{"pmid":"22301499","id":"PMC_22301499","title":"Expression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfall.","date":"2012","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22301499","citation_count":43,"is_preprint":false},{"pmid":"31927554","id":"PMC_31927554","title":"Oct-4 Enhanced the Therapeutic Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Acute Kidney Injury.","date":"2020","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/31927554","citation_count":43,"is_preprint":false},{"pmid":"21075367","id":"PMC_21075367","title":"Expression of oct-4 and c-kit antigens in endometriosis.","date":"2011","source":"Fertility and sterility","url":"https://pubmed.ncbi.nlm.nih.gov/21075367","citation_count":43,"is_preprint":false},{"pmid":"32027821","id":"PMC_32027821","title":"Nucleosomal DNA Dynamics Mediate Oct4 Pioneer Factor Binding.","date":"2020","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/32027821","citation_count":42,"is_preprint":false},{"pmid":"24211655","id":"PMC_24211655","title":"A Pou5f1/Oct4 dependent Klf2a, Klf2b, and Klf17 regulatory sub-network contributes to EVL and ectoderm development during zebrafish embryogenesis.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24211655","citation_count":41,"is_preprint":false},{"pmid":"21533858","id":"PMC_21533858","title":"Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence.","date":"2011","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21533858","citation_count":41,"is_preprint":false},{"pmid":"19732419","id":"PMC_19732419","title":"Promoter analysis of the rabbit POU5F1 gene and its expression in preimplantation stage embryos.","date":"2009","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19732419","citation_count":40,"is_preprint":false},{"pmid":"21621531","id":"PMC_21621531","title":"Pou5f1 contributes to dorsoventral patterning by positive regulation of vox and modulation of fgf8a expression.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21621531","citation_count":40,"is_preprint":false},{"pmid":"17113034","id":"PMC_17113034","title":"Dicer1 expression in preimplantation mouse embryos: Involvement of Oct3/4 transcription at the blastocyst stage.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17113034","citation_count":37,"is_preprint":false},{"pmid":"28378634","id":"PMC_28378634","title":"Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).","date":"2017","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28378634","citation_count":34,"is_preprint":false},{"pmid":"21913309","id":"PMC_21913309","title":"Pou5f1/oct4 in pluripotency control: insights from zebrafish.","date":"2012","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/21913309","citation_count":33,"is_preprint":false},{"pmid":"28813671","id":"PMC_28813671","title":"OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28813671","citation_count":33,"is_preprint":false},{"pmid":"22207173","id":"PMC_22207173","title":"Co-expression of Oct-4 and Nestin in human breast cancers.","date":"2011","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/22207173","citation_count":31,"is_preprint":false},{"pmid":"18471437","id":"PMC_18471437","title":"Stem cell-specific expression of Dax1 is conferred by STAT3 and Oct3/4 in embryonic stem cells.","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18471437","citation_count":30,"is_preprint":false},{"pmid":"37327775","id":"PMC_37327775","title":"Structural mechanism of LIN28B nucleosome targeting by OCT4.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/37327775","citation_count":29,"is_preprint":false},{"pmid":"30269953","id":"PMC_30269953","title":"Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition.","date":"2018","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30269953","citation_count":28,"is_preprint":false},{"pmid":"19537945","id":"PMC_19537945","title":"Inner cell mass localization of NANOG precedes OCT3/4 in rhesus monkey blastocysts.","date":"2009","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/19537945","citation_count":28,"is_preprint":false},{"pmid":"35325071","id":"PMC_35325071","title":"Endothelial OCT4 is atheroprotective by preventing metabolic and phenotypic dysfunction.","date":"2022","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/35325071","citation_count":27,"is_preprint":false},{"pmid":"23933063","id":"PMC_23933063","title":"Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.","date":"2013","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23933063","citation_count":26,"is_preprint":false},{"pmid":"32531293","id":"PMC_32531293","title":"Roles of OCT4 in pathways of embryonic development and cancer progression.","date":"2020","source":"Mechanisms of ageing and development","url":"https://pubmed.ncbi.nlm.nih.gov/32531293","citation_count":25,"is_preprint":false},{"pmid":"25062118","id":"PMC_25062118","title":"Expression of Ki-67, Oct-4, γ-tubulin and α-tubulin in human tooth development.","date":"2014","source":"Archives of oral biology","url":"https://pubmed.ncbi.nlm.nih.gov/25062118","citation_count":25,"is_preprint":false},{"pmid":"24581739","id":"PMC_24581739","title":"An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility.","date":"2014","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24581739","citation_count":25,"is_preprint":false},{"pmid":"23549118","id":"PMC_23549118","title":"The interactomes of POU5F1 and SOX2 enhancers in human embryonic stem cells.","date":"2013","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/23549118","citation_count":25,"is_preprint":false},{"pmid":"26931354","id":"PMC_26931354","title":"POU5F1/Oct-4 expression in breast cancer tissue is significantly associated with non-sentinel lymph node metastasis.","date":"2016","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26931354","citation_count":24,"is_preprint":false},{"pmid":"17682839","id":"PMC_17682839","title":"Aberrant expression and distribution of the OCT-4 transcription factor in seminomas.","date":"2007","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/17682839","citation_count":24,"is_preprint":false},{"pmid":"35123545","id":"PMC_35123545","title":"Additional evidence to support OCT-4 positive VSELs and EnSCs as the elusive tissue-resident stem/progenitor cells in adult mice uterus.","date":"2022","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35123545","citation_count":23,"is_preprint":false},{"pmid":"23451132","id":"PMC_23451132","title":"Involvement of crosstalk between Oct4 and Meis1a in neural cell fate decision.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23451132","citation_count":22,"is_preprint":false},{"pmid":"33990627","id":"PMC_33990627","title":"HNF1A regulates colorectal cancer progression and drug resistance as a downstream of POU5F1.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33990627","citation_count":21,"is_preprint":false},{"pmid":"24532469","id":"PMC_24532469","title":"Clinical significance of the stem cell gene Oct-4 in cervical cancer.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24532469","citation_count":21,"is_preprint":false},{"pmid":"36130732","id":"PMC_36130732","title":"OCT4 interprets and enhances nucleosome flexibility.","date":"2022","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36130732","citation_count":20,"is_preprint":false},{"pmid":"26417682","id":"PMC_26417682","title":"DPF2 regulates OCT4 protein level and nuclear distribution.","date":"2015","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/26417682","citation_count":20,"is_preprint":false},{"pmid":"34143975","id":"PMC_34143975","title":"Auxin-degron system identifies immediate mechanisms of OCT4.","date":"2021","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34143975","citation_count":20,"is_preprint":false},{"pmid":"35547745","id":"PMC_35547745","title":"Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/35547745","citation_count":20,"is_preprint":false},{"pmid":"32557980","id":"PMC_32557980","title":"Undifferentiated round cell sarcomas with novel SS18-POU5F1 fusions.","date":"2020","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32557980","citation_count":20,"is_preprint":false},{"pmid":"18616941","id":"PMC_18616941","title":"Nitric oxide enhances Oct-4 expression in bone marrow stem cells and promotes endothelial differentiation.","date":"2008","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18616941","citation_count":20,"is_preprint":false},{"pmid":"32219062","id":"PMC_32219062","title":"Role of Oct3/4 in Cervical Cancer Tumorigenesis.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32219062","citation_count":19,"is_preprint":false},{"pmid":"29620155","id":"PMC_29620155","title":"Differential expression of Oct3/4 in human breast cancer and normal tissues.","date":"2018","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29620155","citation_count":19,"is_preprint":false},{"pmid":"18231740","id":"PMC_18231740","title":"Expression and significance of Oct4 in bladder cancer.","date":"2007","source":"Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban","url":"https://pubmed.ncbi.nlm.nih.gov/18231740","citation_count":19,"is_preprint":false},{"pmid":"35486003","id":"PMC_35486003","title":"OCT4/POU5F1 is indispensable for the lineage differentiation of the inner cell mass in bovine embryos.","date":"2022","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/35486003","citation_count":18,"is_preprint":false},{"pmid":"17564582","id":"PMC_17564582","title":"The EWS-Oct-4 fusion gene encodes a transforming gene.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17564582","citation_count":18,"is_preprint":false},{"pmid":"22381206","id":"PMC_22381206","title":"Spatial and temporal distribution of Oct-4 and acetylated H4K5 in rabbit embryos.","date":"2012","source":"Reproductive biomedicine online","url":"https://pubmed.ncbi.nlm.nih.gov/22381206","citation_count":18,"is_preprint":false},{"pmid":"22161644","id":"PMC_22161644","title":"Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.","date":"2013","source":"Stem cell reviews and reports","url":"https://pubmed.ncbi.nlm.nih.gov/22161644","citation_count":18,"is_preprint":false},{"pmid":"18295396","id":"PMC_18295396","title":"Participation of OCT3/4 and beta-catenin during dysgenetic gonadal malignant transformation.","date":"2008","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/18295396","citation_count":17,"is_preprint":false},{"pmid":"35218417","id":"PMC_35218417","title":"Olfactomedin-4 improves cutaneous wound healing by promoting skin cell proliferation and migration through POU5F1/OCT4 and ESR1 signalling cascades.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/35218417","citation_count":17,"is_preprint":false},{"pmid":"8500351","id":"PMC_8500351","title":"In situ hybridization localizes the human OTF3 to chromosome 6p21.3-->p22 and OTF3L to 12p13.","date":"1993","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8500351","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46378,"output_tokens":7400,"usd":0.125067,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16734,"output_tokens":6058,"usd":0.11756,"stage2_stop_reason":"end_turn"},"total_usd":0.242627,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"Oct3/4 and Cdx2 form a protein complex in ES cells that mediates reciprocal repression of their respective target genes; Cdx2 overexpression is sufficient to generate trophoblast stem cells and can mimic Oct3/4 repression-induced TE differentiation, while Cdx2 is dispensable for TE differentiation induced by Oct3/4 repression but essential for TS cell self-renewal.\",\n      \"method\": \"Forced expression/repression experiments in ES cells, co-immunoprecipitation to detect Oct3/4-Cdx2 complex, target gene analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, multiple orthogonal functional experiments, replicated across conditions in a rigorous single study\",\n      \"pmids\": [\"16325584\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sox2's essential function in ES cells is to maintain the requisite level of Oct3/4 expression by regulating multiple transcription factors that affect Oct3/4 transcription; forced expression of Oct3/4 rescues pluripotency of Sox2-null ES cells, demonstrating that Oct3/4 is the key downstream effector of Sox2.\",\n      \"method\": \"Inducible Sox2-null ES cells, rescue experiments with forced Oct3/4 expression, gene expression analysis\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined rescue, multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"17515932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Oct4 and Sox2 bind cooperatively to a composite sox-oct element in the distal enhancer of Pou5f1 (Oct4 gene itself) and the Sox2 enhancer in living ES cells, forming a positive autoregulatory loop; knockdown of either factor reduces both genes' enhancer activities and causes ES cell differentiation.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) in mouse and human ES cells, in vitro binding with ESC nuclear extracts, RNAi knockdown\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal ChIP, in vitro binding, RNAi functional validation, replicated in two species\",\n      \"pmids\": [\"15988017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"OCT4 and SOX2 bind nucleosome-occupied motifs in a position-dependent manner: at one motif position the OCT4-SOX2 complex removes DNA from histones H2A and H3, while at an inverted motif only local DNA distortions are induced; OCT4 uses only one of its two DNA-binding domains (POUHD) at both positions.\",\n      \"method\": \"Cryo-electron microscopy structure determination, in vitro nucleosome binding assays at base-pair resolution, mutagenesis\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structures at two positions combined with in vitro biochemical assays and mutagenesis in a single rigorous study\",\n      \"pmids\": [\"32327602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Zebrafish Pou5f1 (ortholog of mammalian Oct4) occupies SOX-POU binding sites at promoters of early zygotic genes before the onset of zygotic transcription and activates the earliest zygotic genes, positioning Pou5f1 and SOX-POU sites at the center of the zygotic gene activation network in vertebrates.\",\n      \"method\": \"ChIP-seq, transcriptome analysis of MZspg mutants, transgenic rescue experiments in zebrafish\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq plus loss-of-function genetics with transcriptome readout, multiple orthogonal methods\",\n      \"pmids\": [\"23950494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Klf4 cooperates with Oct3/4 and Sox2 to activate the Lefty1 core promoter in ES cells; Klf4 acts as a mediating factor that binds specifically to the proximal element of the Lefty1 promoter and is required because the Oct3/4-Sox2-dependent Lefty1 enhancer alone cannot be activated in differentiated cells.\",\n      \"method\": \"ES cell-specific enhancer identification, functional screening of ES-specific transcription factors, reporter assays, DNA microarray analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assays with multiple factors, single lab, supported by microarray data\",\n      \"pmids\": [\"16954384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Oct-4 and adenovirus E1A are sufficient for distance-independent activation of the basal transcription machinery; E1A binds to the C-terminal POU domain of Oct-4 and can serve as a bridging factor between Oct-4 and the basal initiation complex; transcriptional activation depends on the transactivation domain linked to the POU domain and conserved domain 3 of E1A.\",\n      \"method\": \"Transient transfection reporter assays, deletion analysis of Oct-4 functional domains, protein interaction studies\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional domain deletion analysis with reporter assays, protein interaction mapping, single lab\",\n      \"pmids\": [\"1830243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dax1 (an orphan nuclear hormone receptor) directly interacts with Oct3/4 via the POU-specific domain of Oct3/4 in ES cells; this interaction abolishes DNA binding activity of Oct3/4 as shown by pulldown and gel shift assays; Dax1 inhibits Oct3/4 binding to Nanog and Oct3/4 promoter regions and its overexpression causes ES cell differentiation.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown, gel shift assays, ChIP, reporter assays, overexpression/knockdown in ES cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal biochemical methods (Co-IP, pulldown, gel shift, ChIP) converging on same mechanism in single study\",\n      \"pmids\": [\"19528230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Ewing's sarcoma protein (EWS) interacts with Oct-4 via the POU domain of Oct-4 (with three independent binding sites on EWS), co-localizes with Oct-4 in pluripotent ES cells, and enhances Oct-4 transactivation activity; the EWS activation domain is sufficient to boost Oct-4-driven promoter activity.\",\n      \"method\": \"Bacterial two-hybrid screening, GST pulldown, co-immunoprecipitation, colocalization, reporter transactivation assays\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal pulldown and Co-IP plus functional reporter assays, single lab\",\n      \"pmids\": [\"15917470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"OCT4 is phosphorylated at 14 sites including T234 and S235 within the homeobox region; phosphorylation at T234/S235 negatively regulates OCT4 by interrupting sequence-specific DNA binding, reducing transcriptional activation from an OCT4-responsive reporter and decreasing reprogramming efficiency; ERK2 directly phosphorylates OCT4 at these sites in vitro.\",\n      \"method\": \"LC-MS/MS phosphoproteomics, mutagenesis of phosphorylation sites, reporter assays, reprogramming efficiency assays, in vitro kinase assays with ERK2\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay plus mutagenesis plus functional reporter and reprogramming readouts, multiple orthogonal methods in single study\",\n      \"pmids\": [\"22474382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Oct-4 controls cell-cycle progression of ES cells: Oct-4 down-regulation inhibits proliferation by blocking G0/G1 progression; the p21 gene is a direct transcriptional target of Oct-4 repression, and p21 protein levels are inversely regulated by Oct-4 in ES cells.\",\n      \"method\": \"ZHBTc4 ES cells (inducible Oct-4 repression), flow cytometry cell cycle analysis, domain deletion analysis, reporter assays for p21\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible KO system with defined cell-cycle phenotype and target gene identification, single lab\",\n      \"pmids\": [\"19968627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Oct3/4 is required for primordial germ cell (PGC) specification: ES-derived cells lacking Oct3/4 contribute to PGC precursor-like cells but fail to form PGCs in chimeric embryos; restoration of Oct3/4 expression rescues PGC specification.\",\n      \"method\": \"Chimeric embryo analysis with ZHBTc4 Oct3/4-null ES cells, doxycycline-controlled transgene system, dexamethasone-inducible rescue\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic loss-of-function with rescue experiment, two independent inducible systems confirming the same result\",\n      \"pmids\": [\"18395706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CRISPR-Cas9 knockout of POU5F1 in human zygotes compromises blastocyst development; in POU5F1-null human cells, CDX2 (trophectoderm marker) and NANOG (epiblast marker) are both downregulated—contrasting with mouse where Pou5f1-null blastocysts maintain NANOG and only fail to maintain the blastocyst.\",\n      \"method\": \"CRISPR-Cas9 genome editing of human zygotes, single-cell transcriptomics, immunofluorescence\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct genetic loss-of-function in human embryos with transcriptomic readout, validated against mouse comparison\",\n      \"pmids\": [\"28953884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"OCT4 knockout in bovine embryos (via CRISPR/SCNT) results in absence of NANOG expression in the ICM of blastocysts while CDX2 remains restricted to TE cells; OCT4 is thus required for NANOG expression but not to suppress CDX2 in bovine ICM, mirroring human but not mouse embryology.\",\n      \"method\": \"CRISPR-Cas9 OCT4 knockout, somatic cell nuclear transfer, immunofluorescence in bovine blastocysts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct genetic KO in a non-mouse mammalian model, multiple lineage markers assessed, convergent with human data\",\n      \"pmids\": [\"29483258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Rapid auxin-degron-mediated OCT4 depletion shows that immediate downstream effects of OCT4 loss are reduced expression of key pluripotency factors and global depletion of H3K27ac at active enhancers; trophectoderm marker upregulation is a subsequent rather than immediate event; NANOG binding to the genome is enhanced (not reduced) upon OCT4 loss.\",\n      \"method\": \"Auxin-inducible degron system for rapid protein depletion, ChIP-seq for H3K27ac, NANOG ChIP-seq, transcriptomics\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — acute protein depletion system with ChIP-seq and transcriptomic readouts, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"34143975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"OCT4 is required for activation of the JAK/STAT signaling machinery (but not most other pluripotency-associated transcription factors) in the early mouse embryo ICM; OCT4 null ICMs ectopically activate trophectoderm genes and show upregulation of the lysosomal pathway and dysregulation of glycolytic enzymes, implicating OCT4 in metabolic regulation.\",\n      \"method\": \"Single-cell transcriptomics and quantitative immunofluorescence of OCT4-null blastocysts\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-cell transcriptomics of genetic KO embryos, single lab, mechanistic inference from pathway analysis\",\n      \"pmids\": [\"33452132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"OCT4 binds low-accessible genomic regions and is required for proper enhancer and gene activation in response to external differentiation signals (RA/RAR:RXR or Wnt/β-catenin); OCT4 recruits co-regulators and signal-dependent transcription factors to these sites, acting as an integral component of signal-regulated transcriptional processes.\",\n      \"method\": \"Genomic approaches (ChIP-seq), loss- and gain-of-function genetic models, overexpression in kidney cell line\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq with genetic loss/gain-of-function, multiple genomic datasets, single lab\",\n      \"pmids\": [\"27499297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Nucleosome binding by OCT4 is encoded within its DNA-binding domain but can be uncoupled from free-DNA binding; stable OCT4-nucleosome interactions are continuously required for maintaining accessibility of pluripotency enhancers in stem cells; both uncoupling and enhancing nucleosome binding are detrimental to reprogramming efficiency.\",\n      \"method\": \"Systematic domain dissection/mutagenesis, ATAC-seq, ChIP-seq, reprogramming efficiency assays\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — systematic mutagenesis with multiple orthogonal genomic and functional readouts in a single comprehensive study\",\n      \"pmids\": [\"34354236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"OCT4 binds the LIN28B distal enhancer nucleosome preferentially at sequences near the entry/exit site; OCT4 contacts the histone H3 N-terminal region (near entry/exit site) as shown by crosslinking mass spectrometry; linker histone H1 competes with OCT4 for nucleosome binding.\",\n      \"method\": \"Cryo-EM single-particle analysis, chemical mapping, crosslinking mass spectrometry, mutational analysis, in vitro nucleosome binding assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure combined with chemical mapping and crosslinking MS, multiple orthogonal structural methods, single lab\",\n      \"pmids\": [\"32678275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"High-resolution cryo-EM structures of OCT4 bound to LIN28B nucleosome reveal three OCT4s binding pre-positioned nucleosomal DNA: two use POUS domains, one uses POUS-loop-POUHD; the POUHD domain acts as a wedge to unwrap ~25 bp of DNA; multiple OCT4s cooperatively open H1-condensed nucleosome arrays.\",\n      \"method\": \"Cryo-EM structure determination, biochemical nucleosome binding and opening assays, analysis of genomic data\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution cryo-EM structures with biochemical functional validation and genomic data analysis\",\n      \"pmids\": [\"37327775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"WWP2 catalyzes ubiquitination of OCT4; disruption of WWP2-mediated ubiquitination or Wwp2 ablation increases OCT4 protein stability and promotes reprogramming efficiency; elevated H3K4 methylation accompanies increased OCT4 stability; OCT4 directly activates expression of Ash2l-b, a H3K4 methyltransferase complex subunit required for reprogramming.\",\n      \"method\": \"Identification of ubiquitin conjugation sites, in vitro ubiquitination assays, Wwp2 knockout mouse embryonic fibroblasts, reprogramming efficiency assays, ChIP\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro ubiquitination assay plus genetic KO plus reprogramming functional readout, multiple orthogonal methods\",\n      \"pmids\": [\"30269953\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DPF2 (a PHD finger protein) physically interacts with OCT4 in ES cells and acts as an E3 ubiquitin ligase that assembles K48-linked polyubiquitin chains on OCT4, targeting it for proteasomal degradation; DPF2 also redistributes nuclear OCT4 independently of ubiquitination.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown, in vitro ubiquitination assay, siRNA knockdown, overexpression in 293 cells\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro ubiquitination assay and Co-IP/pulldown, single lab, multiple methods\",\n      \"pmids\": [\"26417682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Oct3/4 expression in ES cells is regulated by STAT3 and Oct3/4 itself; both STAT3 and Oct3/4 directly bind putative sites in the Dax1 promoter/enhancer region; suppression of STAT3 or Oct3/4 reduces Dax1 expression, establishing that Oct3/4 activates Dax1 transcription to maintain ES cell self-renewal.\",\n      \"method\": \"Reporter assay, ChIP, gel shift assay, siRNA knockdown\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus gel shift plus reporter assays, single lab\",\n      \"pmids\": [\"18471437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Zebrafish pou5f1/pou2 (maternal and zygotic) is required for endoderm specification: maternal-zygotic spg mutants fail to maintain sox32 expression and do not express sox17, resulting in loss of endodermal tissue; Pou5f1 acts upstream of sox32 to induce sox17 in endodermal precursors; a Pou5f1-VP16 activator fusion rescues gastrulation and endoderm.\",\n      \"method\": \"Maternal-zygotic mutant (MZspg) analysis, mRNA rescue injection, Pou5f1-VP16 overexpression, gene expression analysis in zebrafish\",\n      \"journal\": \"Current biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis via maternal-zygotic mutant plus activator fusion rescue, clean pathway placement\",\n      \"pmids\": [\"14711414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In zebrafish, Pou5f1 acts as a transcriptional activator for dorsoventral patterning; Pou5f1 directly binds phylogenetically conserved Oct/Pou5f1 sites in the vox promoter (confirmed by ChIP and in vitro binding); Pou5f1 indirectly controls fgf8a expression (Pou5f1-En repressor induces fgf8, suggesting repression), and coordinates BMP signaling network activity.\",\n      \"method\": \"Pou5f1-VP16 and Pou5f1-En fusion overexpression in zebrafish, ChIP, in vitro DNA binding, cycloheximide treatment to distinguish direct vs indirect targets\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus in vitro binding plus functional fusion protein experiments, single lab\",\n      \"pmids\": [\"21621531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NOBOX binds directly to NOBOX binding elements (NBEs: TAATTG, TAGTTG, TAATTA) in the Pou5f1 promoter (-426 site) and augments Pou5f1 transcriptional activity; NOBOX occupies the Pou5f1 promoter in vivo as shown by ChIP.\",\n      \"method\": \"SELEX (cyclic amplification of sequence target), mutation analysis, luciferase reporter assay, ChIP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — SELEX binding characterization plus ChIP plus reporter assay, single lab\",\n      \"pmids\": [\"16997917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The proximal Oct-4 promoter contains binding sites for Sp1 and three direct repeats of an AGGTCA-like sequence; nuclear receptors ARP-1 and RAR negatively regulate Oct-4 expression by binding these elements as shown by binding and transient transfection assays.\",\n      \"method\": \"Binding assays, transient transfection reporter assays, promoter deletion analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — binding assays plus functional reporter assays, single lab\",\n      \"pmids\": [\"8152920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Oct4 transiently activates Meis1a expression via direct binding to the Meis1 promoter (accompanied by histone H3 acetylation and 5-hmC), while Meis1a in turn suppresses Oct4 expression by direct association with the Oct4 promoter together with HDAC1; this crosstalk is required for neural differentiation.\",\n      \"method\": \"ChIP, luciferase reporter analysis, ectopic expression, siRNA knockdown in P19 EC cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assays plus reciprocal loss/gain of function, single lab\",\n      \"pmids\": [\"23451132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"OCT4 and SOX2 function as transcriptional activators during reprogramming; substituting SOX2-VP16 for wild-type SOX2 increases reprogramming efficiency and enhancer strength, while SOX2-HP1 (repressor) eliminates reprogramming; at early reprogramming stages, DNA-bound OCT4 is embedded in putative enhancers, about half of which are created de novo.\",\n      \"method\": \"Reprogramming efficiency assays with activation/repression domain fusions, ChIP-seq at early reprogramming stages\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional domain swap with ChIP-seq, single lab, clean epistatic readout\",\n      \"pmids\": [\"28813671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The EWSR1-POU5F1 fusion protein (from t(6;22) bone tumor) binds DNA with the same sequence specificity as Oct-4, has higher transactivation activity than parental Oct-4, induces expression of fgf-4 and nanog, and causes tumorigenic growth in nude mice when expressed in Oct-4-null ES cells, establishing the fusion as an oncogenic transcription factor.\",\n      \"method\": \"DNA binding assays, reporter assays, target gene expression analysis (fgf-4, nanog), nude mouse tumorigenicity assay with Oct-4-null ZHBTc4 ES cells\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional biochemical assays plus in vivo tumorigenic assay, single lab\",\n      \"pmids\": [\"17564582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In endothelial cells, OCT4 directly targets the ABC transporter ABCG2; the OCT4/ABCG2 axis maintains endothelial metabolic homeostasis by regulating intracellular heme accumulation and related ROS production; EC-specific Oct4 knockout increases endothelial-to-mesenchymal transitions, plaque neovascularization, and mitochondrial dysfunction.\",\n      \"method\": \"EC-specific Oct4 conditional KO mice, single-cell RNA-seq, EC-lineage tracing, ChIP to confirm ABCG2 as direct OCT4 target\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined phenotype and direct target identification by ChIP, single lab\",\n      \"pmids\": [\"35325071\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POU5F1/OCT4 is a pioneer POU-family transcription factor that maintains pluripotency by forming cooperative complexes with SOX2, NANOG, and KLF4 to activate or repress target gene networks; it directly binds nucleosomal DNA using its POUS and POUHD domains to open chromatin at pluripotency enhancers, is negatively regulated by phosphorylation (ERK2 at T234/S235) and ubiquitination (WWP2-mediated K48-linked polyubiquitin/proteasomal degradation), is inhibited by DAX1 binding to its POU-specific domain which blocks DNA binding, represses p21 to promote cell-cycle S-phase entry in ES cells, and is required cell-autonomously for NANOG expression and inner cell mass lineage maintenance in mammalian blastocysts while also directing primordial germ cell specification and, in zebrafish, zygotic genome activation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POU5F1/OCT4 is a POU-family transcription factor that establishes and maintains the pluripotent state by acting as a pioneer factor capable of engaging nucleosomal DNA at otherwise inaccessible regulatory elements [#3, #17]. OCT4 operates within a self-reinforcing core network: it binds cooperatively with SOX2 at a composite sox-oct element in its own distal enhancer and in the Sox2 enhancer, forming a positive autoregulatory loop whose disruption triggers differentiation [#2], and SOX2's essential contribution is to sustain OCT4 levels, with forced OCT4 expression rescuing Sox2-null cells [#1]. At target loci OCT4 recruits additional factors\\u2014KLF4 at the Lefty1 promoter [#5]\\u2014and integrates signal-dependent transcription factors at low-accessibility enhancers during RA and Wnt responses [#16], while its reciprocal repressive complex with CDX2 enforces the boundary between pluripotency and trophectoderm fate [#0]. Structurally, OCT4 binds nucleosome-occluded motifs in a position-dependent manner, using its POUHD domain as a wedge to unwrap DNA from histones, contacting the histone H3 N-terminal region near the entry/exit site, and acting in multiples to cooperatively open H1-condensed nucleosome arrays\\u2014an activity continuously required to maintain enhancer accessibility [#3, #18, #19, #17]. OCT4 activity is tuned by post-translational control: ERK2 phosphorylates it at T234/S235 within the homeobox to block DNA binding [#9], WWP2 ubiquitinates it to limit protein stability [#20], and DAX1 binds the POU-specific domain to abolish DNA binding [#7]; reciprocally, OCT4 directly activates Dax1 transcription, creating a feedback circuit [#22]. Functionally, OCT4 represses p21 to promote cell-cycle progression in ES cells [#10], is required for primordial germ cell specification [#11], and is essential for maintaining the inner cell mass and NANOG expression in human and bovine blastocysts [#12, #13]. In zebrafish the ortholog drives zygotic genome activation and germ-layer patterning [#4, #23]. The EWSR1-POU5F1 fusion behaves as an oncogenic transcription factor with OCT4 DNA-binding specificity and elevated transactivation [#29].\",\n  \"teleology\": [\n    {\n      \"year\": 1991,\n      \"claim\": \"Established that OCT4 functions as a transcriptional activator able to engage the basal machinery through its POU and transactivation domains, defining its activity as a sequence-specific activator.\",\n      \"evidence\": \"Transient transfection reporter assays with domain deletion and E1A bridging in cultured cells\",\n      \"pmids\": [\"1830243\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Used a viral bridging factor rather than endogenous coactivators\", \"Did not address chromatin or nucleosomal targets\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Defined how OCT4 expression itself is set, showing nuclear receptors ARP-1 and RAR negatively regulate the proximal Oct-4 promoter, placing OCT4 under upstream signal control.\",\n      \"evidence\": \"Binding and transient transfection reporter assays with promoter deletions\",\n      \"pmids\": [\"8152920\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Promoter-reporter context only\", \"In vivo relevance to embryonic regulation not tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed the OCT4 ortholog in a developmental hierarchy, showing zebrafish Pou5f1 acts upstream of sox32 to specify endoderm, demonstrating an instructive role in germ-layer fate beyond stem cell maintenance.\",\n      \"evidence\": \"Maternal-zygotic spg mutant analysis with mRNA and Pou5f1-VP16 rescue in zebrafish\",\n      \"pmids\": [\"14711414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect targets of sox32 induction not fully resolved\", \"Mammalian endoderm relevance not addressed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved the core pluripotency wiring, showing OCT4 and SOX2 bind cooperatively to a composite element to form a positive autoregulatory loop sustaining both genes.\",\n      \"evidence\": \"ChIP in mouse and human ES cells, in vitro binding, and RNAi knockdown\",\n      \"pmids\": [\"15988017\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish nucleosomal binding mode\", \"Full enhancer co-factor composition not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated reciprocal antagonism between OCT4 and CDX2 as the molecular switch governing the pluripotency-versus-trophectoderm decision.\",\n      \"evidence\": \"Forced expression/repression in ES cells with Co-IP and target gene analysis\",\n      \"pmids\": [\"16325584\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural basis of the OCT4-CDX2 complex unknown\", \"Generality across species not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identified EWS as an OCT4 coactivator binding the POU domain, beginning to define the partner proteins that potentiate OCT4 transactivation.\",\n      \"evidence\": \"Bacterial two-hybrid, GST pulldown, Co-IP, colocalization, and reporter assays\",\n      \"pmids\": [\"15917470\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous requirement in ES cells not shown by loss-of-function\", \"Single-lab interaction mapping\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed OCT4 acts combinatorially with KLF4 to activate target promoters, explaining why OCT4-SOX2 enhancers require additional context-specific mediators.\",\n      \"evidence\": \"Reporter assays, factor screening, and microarray analysis in ES cells\",\n      \"pmids\": [\"16954384\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single target locus (Lefty1) examined\", \"Direct OCT4-KLF4 physical interaction not established\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Established that SOX2's essential role in ES cells is to maintain OCT4 levels, ordering the network with OCT4 as the key downstream effector.\",\n      \"evidence\": \"Inducible Sox2-null ES cells rescued by forced Oct3/4 expression\",\n      \"pmids\": [\"17515932\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not exclude SOX2-independent OCT4 functions\", \"Mechanism of indirect OCT4 regulation by SOX2 only partly defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Connected OCT4 to germ-cell fate and to a feedback circuit, showing OCT4 is required cell-autonomously for primordial germ cell specification and directly activates Dax1 transcription.\",\n      \"evidence\": \"Chimeric embryo analysis with inducible Oct3/4-null ES cells; ChIP, gel shift, and reporter assays for Dax1\",\n      \"pmids\": [\"18395706\", \"18471437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct OCT4 PGC target genes not enumerated\", \"Functional consequence of the OCT4-Dax1 loop on threshold control not quantified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identified DAX1 as a direct inhibitor that binds the OCT4 POU-specific domain and abolishes DNA binding, defining a protein-level off-switch.\",\n      \"evidence\": \"Co-IP, GST pulldown, gel shift, ChIP, and reporter assays in ES cells\",\n      \"pmids\": [\"19528230\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological trigger for DAX1-mediated inhibition unclear\", \"Stoichiometric regulation of the OCT4/DAX1 feedback not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Linked OCT4 to cell-cycle control, showing it directly represses p21 to promote G0/G1 progression in ES cells.\",\n      \"evidence\": \"Inducible Oct-4 repression, flow cytometry, domain deletion, and p21 reporter assays\",\n      \"pmids\": [\"19968627\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding at the endogenous p21 locus only inferred from reporter\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Defined a kinase-driven brake on OCT4, showing ERK2 phosphorylates T234/S235 in the homeobox to interrupt DNA binding and lower reprogramming efficiency.\",\n      \"evidence\": \"Phosphoproteomics, site mutagenesis, in vitro ERK2 kinase assay, and reporter/reprogramming readouts\",\n      \"pmids\": [\"22474382\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling ERK2-OCT4 phosphorylation in vivo not mapped\", \"Other phosphosites' functions unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Generalized OCT4 to vertebrate zygotic genome activation, showing zebrafish Pou5f1 occupies SOX-POU sites and activates the earliest zygotic genes before transcription onset.\",\n      \"evidence\": \"ChIP-seq and transcriptome analysis of MZspg mutants with transgenic rescue\",\n      \"pmids\": [\"23950494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pioneer mechanism at ZGA loci not structurally resolved here\", \"Mammalian ZGA role not directly tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed OCT4 binds low-accessibility regions and recruits signal-dependent factors, casting it as an integrator of external differentiation signals rather than a pluripotency-only factor.\",\n      \"evidence\": \"ChIP-seq with loss/gain-of-function in genetic models and a kidney cell line\",\n      \"pmids\": [\"27499297\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-regulator identity at signal-responsive sites only partly defined\", \"Performed in part in a non-pluripotent cell line\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided the structural mechanism of OCT4 as a pioneer factor, showing position-dependent nucleosome engagement that removes DNA from histones using a single DNA-binding domain.\",\n      \"evidence\": \"Cryo-EM at base-pair resolution with in vitro nucleosome binding and mutagenesis; complementary cryo-EM/crosslinking MS at the LIN28B enhancer\",\n      \"pmids\": [\"32327602\", \"32678275\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro reconstitution may not capture full cellular cofactor context\", \"How motif orientation maps to genome-wide outcomes unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Dissected the temporal and structural requirements of OCT4 in stem cells, showing nucleosome binding is encoded in the DBD, must be balanced for reprogramming, and that acute OCT4 loss first collapses enhancer H3K27ac and pluripotency factor expression.\",\n      \"evidence\": \"Systematic mutagenesis with ATAC/ChIP-seq; auxin-degron rapid depletion with H3K27ac and NANOG ChIP-seq\",\n      \"pmids\": [\"34354236\", \"34143975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which NANOG binding increases upon OCT4 loss not explained\", \"Direct vs indirect enhancer effects not fully separated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Extended OCT4's embryonic role to signaling and metabolism, showing it is required for JAK/STAT activation and metabolic gene regulation in the ICM.\",\n      \"evidence\": \"Single-cell transcriptomics and quantitative immunofluorescence of OCT4-null mouse blastocysts\",\n      \"pmids\": [\"33452132\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct OCT4 targets in the JAK/STAT and metabolic pathways not defined\", \"Mechanistic inference from pathway-level transcriptomics\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed species-specific lineage requirements, showing human POU5F1 loss downregulates both NANOG and CDX2, contrasting with the mouse trophectoderm-restriction model.\",\n      \"evidence\": \"CRISPR-Cas9 editing of human zygotes with single-cell transcriptomics and immunofluorescence\",\n      \"pmids\": [\"28953884\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of human-mouse divergence not resolved\", \"Direct human OCT4 target genes not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Confirmed the human-like requirement in a second mammal and defined OCT4 protein turnover, showing OCT4 is needed for NANOG in bovine ICM and that WWP2 ubiquitination limits OCT4 stability and reprogramming.\",\n      \"evidence\": \"CRISPR/SCNT knockout in bovine embryos; ubiquitination site mapping, in vitro ubiquitination, Wwp2-null MEFs, and reprogramming assays\",\n      \"pmids\": [\"29483258\", \"30269953\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals controlling WWP2-OCT4 turnover in vivo not defined\", \"Link between OCT4 stability and H3K4 methylation only correlative in part\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Achieved high-resolution mechanism of cooperative chromatin opening, showing three OCT4 molecules engage a pre-positioned nucleosome and use POUHD as a wedge to unwrap DNA and open H1-condensed arrays.\",\n      \"evidence\": \"High-resolution cryo-EM with biochemical nucleosome opening assays and genomic analysis\",\n      \"pmids\": [\"37327775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo stoichiometry of multi-OCT4 binding not established\", \"How cooperativity is regulated by partner factors unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Documented a somatic, non-pluripotency role, showing OCT4 directly regulates ABCG2 to maintain endothelial metabolic homeostasis and protect against vascular dysfunction.\",\n      \"evidence\": \"EC-specific Oct4 conditional KO mice, scRNA-seq, lineage tracing, and ChIP for ABCG2\",\n      \"pmids\": [\"35325071\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of OCT4 reactivation in adult endothelium unclear\", \"Single-lab, single tissue context\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How OCT4 selects between activation and repression at a given locus, and how its pioneer nucleosome-opening activity is integrated with partner availability, post-translational state, and species-specific lineage outcomes, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking phosphorylation/ubiquitination state to genome-wide binding outcomes\", \"Determinants of activator vs repressor behavior at individual enhancers undefined\", \"Molecular basis of human/bovine vs mouse lineage divergence unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 6, 23, 28, 29]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 7, 9, 17, 19]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [18, 19]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 21]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [3, 17, 18, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 4, 16, 28]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11, 12, 13, 23]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [3, 17, 19]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SOX2\", \"CDX2\", \"DAX1\", \"KLF4\", \"EWS\", \"WWP2\", \"DPF2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}